NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Annual report FY2026 JAGSONPAL PHARMACEUTICALS LIMITED - FY2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹2,872 mn (6.9% YoY growth) • Operating EBITDA: ₹6 | 2026-08-27 |
| Q1 FY27 earnings call JAGSONPAL PHARMACEUTICALS LIMITED – Q1 FY27 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue from operations: Rs.82 crores, up 9% year-on-year • Gross pr | 2026-08-04 |
| Q4 FY26 earnings call JAGSONPAL PHARMACEUTICALS LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • FY26 Revenue: INR287 crores, growth of 7% year-on-year • Q4 FY26 Revenue: INR | 2026-05-04 |
| Quarterly results · Q4 FY26 JAGSONPAL PHARMACEUTICALS LIMITED – FY26 RESULTS SUMMARY HEADLINE NUMBERS • Revenue FY26: ₹2,872 Mn (up 6.9% YoY); Q4FY26: ₹642 Mn (up 9.6% YoY) • O | 2026-04-27 |
| Investor presentation · Q4 FY26 JAGSONPAL PHARMACEUTICALS LIMITED – FY26 RESULTS SUMMARY HEADLINE NUMBERS • Revenue FY26: ₹2,872 Mn, up 6.9% YoY (₹2,687 Mn in FY25) • Q4FY26 Revenu | 2026-04-27 |
| Q3 FY26 earnings call JAGSONPAL PHARMACEUTICALS LIMITED – Q3 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q3 FY26 revenue: INR 73 crores (essentially flat year-on-year, -1% g | 2026-01-27 |
| Investor presentation · Q3 FY26 JAGSONPAL PHARMACEUTICALS LIMITED – Q3 & 9MFY26 FINANCIAL SUMMARY HEADLINE NUMBERS • 9-Month Revenue (9MFY26): ₹2,230 Mn, up 6% YoY from ₹2,102 Mn i | 2026-01-21 |
| Quarterly results · Q3 FY26 JAGSONPAL PHARMACEUTICALS LIMITED - FINANCIAL SUMMARY Q3 & 9-Month Results (December 31, 2025) --- HEADLINE NUMBERS • Q3 FY2026 Revenue from Operat | 2026-01-21 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹4 / share ex-date Sep 4, 2026 | 2026-09-04 |
| Dividend | ₹2.50 / share ex-date Sep 12, 2025 | 2025-09-12 |
| Announcement | Date |
|---|---|
| Updates on acquisition of Aequitas Healthcare Private Limited Jagsonpal Pharmaceuticals Limited announced an acquisition of Aequitas Healthcare Private Limited. This is a strategic move to expand the company's business portfolio and market presence. Ac | 2026-07-17 |
| Acquisition of Aequitas Healthcare Private Limited Jagsonpal Pharmaceuticals Limited announced an update regarding its acquisition of Aequitas Healthcare Private Limited. This acquisition represents a strategic expansion move for the company | 2026-07-08 |
| Acquisition of Aequitas Healthcare Private Limited Jagsonpal Pharmaceuticals Limited announced an acquisition of Aequitas Healthcare Private Limited. This strategic move represents the company's expansion into new business areas or markets. | 2026-07-07 |
| Acquisition of Aequitas Healthcare Private Limited Jagsonpal Pharmaceuticals Limited announced the acquisition of Aequitas Healthcare Private Limited on June 29, 2026. While the specific financial terms were not detailed in this exchange not | 2026-06-29 |
| Acquisition of Aequitas Healthcare Private Limited Jagsonpal Pharmaceuticals Limited has informed the Exchange about Acquisition of Aequitas Healthcare Private Limited. | 2026-06-29 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jagsonpal Pharmaceuticals Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.